Scarica l'app Stockscreener
21.13
6.34%
1.26
Dopo l'orario di chiusura:
21.12
-0.010
-0.05%
Oculis Holding Ag Borsa (OCS) Ultime notizie
Will Oculis Holding AG Equity Warrant price bounce be sustainable2025 Analyst Calls & AI Driven Price Predictions - newser.com
Oculis Holding AG Equity Warrant stock momentum explainedFed Meeting & Daily Growth Stock Tips - newser.com
What recovery options are there for Oculis Holding AG Equity Warrant - newser.com
What to expect from Oculis Holding AG in the next 30 daysTrade Signal Summary & Smart Swing Trading Alerts - newser.com
Can volume confirm reversal in Oculis Holding AG2025 Price Momentum & Reliable Trade Execution Plans - newser.com
Chart based analysis of Oculis Holding AG trendsJuly 2025 Closing Moves & Fast Exit/Entry Strategy Plans - newser.com
Applying chart zones and confluence areas to Oculis Holding AG Equity Warrant2025 Market WrapUp & Scalable Portfolio Growth Ideas - newser.com
Oculis (NASDAQ:OCS) Sees Large Volume Increase Following Analyst Upgrade - Defense World
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - GlobeNewswire
Chardan Research Adjusts Oculis Holding AG Price Target to $51 From $33, Maintains Buy Rating - MarketScreener
Oculis (NASDAQ:OCS) Price Target Raised to $51.00 - MarketBeat
Chardan Capital Maintains Oculis Holding (OCS) Buy Recommendation - Nasdaq
HC Wainwright Issues Positive Forecast for Oculis (NASDAQ:OCS) Stock Price - Defense World
Oculis (NASDAQ:OCS) Sees Unusually-High Trading Volume After Analyst Upgrade - MarketBeat
Oculis (NASDAQ:OCS) Given New $36.00 Price Target at HC Wainwright - MarketBeat
HC Wainwright & Co. Maintains Oculis Holding (OCS) Buy Recommendation - Nasdaq
Oculis stock price target raised to $36 from $33 at H.C. Wainwright - Investing.com
Oculis to launch PIONEER trials for privosegtor in acute optic neuritis and NAION - Ophthalmology Times
Oculis Advances Privosegtor into Registrational Trials for Neuro-Ophthalmology - TipRanks
Does Oculis Holding AG Equity Warrant show high probability of reboundJuly 2025 Rallies & Community Supported Trade Ideas - newser.com
Reversal indicators forming on Oculis Holding AG Equity Warrant stockEarnings Risk Summary & Weekly High Conviction Trade Ideas - newser.com
Oculis Advances Privosegtor Into Registrational Trials for Neuroprotective Therapy - MarketScreener
Will Oculis Holding AG Equity Warrant bounce back from current supportJuly 2025 Weekly Recap & Stepwise Entry/Exit Trade Alerts - newser.com
Why retail traders accumulate Oculis Holding AG (CR5) stockJuly 2025 Review & Weekly Breakout Watchlists - newser.com
Can trapped investors hope for a rebound in Oculis Holding AG Equity WarrantJuly 2025 Recap & Pattern Based Trade Signal System - newser.com
Oculis Accelerates Privosegtor into Registrational Trials in Acute Optic Neuritis, Pioneering the Path for a Potential First-in-class Neuroprotective Therapy - The Manila Times
Oculis Advances Privosegtor into Pivotal Development for Acute Optic Neuritis and NAION Following Positive FDA Meeting - Quiver Quantitative
Will Oculis Holding AG (CR5) stock sustain bullish trend into 2025Trade Risk Report & Risk Adjusted Buy and Sell Alerts - newser.com
3 pivotal trials: Oculis launches PIONEER program for Privosegtor after positive FDA meeting - Stock Titan
Will Oculis Holding AG (CR5) stock benefit from sector leadershipMarket Growth Summary & Safe Capital Investment Plans - newser.com
Brokerages Set Oculis Holding AG (NASDAQ:OCS) PT at $35.75 - Defense World
What machine learning models say about Oculis Holding AG2025 Top Gainers & Free High Return Stock Watch Alerts - newser.com
Published on: 2025-10-05 06:40:04 - newser.com
Why Oculis Holding AG (CR5) stock is favored by hedge fundsMarket Trend Summary & Technical Confirmation Trade Alerts - newser.com
Published on: 2025-10-05 05:35:30 - newser.com
Will Oculis Holding AG rebound enough to break evenGap Down & Daily Risk Controlled Trade Plans - newser.com
Multi factor analysis applied to Oculis Holding AGMarket Sentiment Review & Risk Controlled Daily Trade Plans - newser.com
Sentiment analysis tools applied to Oculis Holding AGSwing Trade & Fast Momentum Stock Entry Tips - newser.com
Oculis Holding AG (NASDAQ:OCS) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Identifying reversal signals in Oculis Holding AG Equity WarrantWeekly Stock Analysis & Free Safe Capital Growth Stock Tips - newser.com
0.74%
1.60%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):